Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NSD2 | O96028 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | TERT | O14746 | 1/20 | 0.42 |
| ▸ | APP | P05067 | 1/20 | 0.42 |
| ▸ | HTR6 | P50406 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | CA9 | Q16790 | 4/20 | 0.39 |
| ▸ | CA2 | P00918 | 4/20 | 0.39 |
| ▸ | CA12 | O43570 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14356134 | 0.83 | NSD2 (0.49) | NSD2ALDH1A1KDM4EHPGDALOX15 | |
| SCHEMBL5666477 | 0.82 | L3MBTL1 (0.46) | ALDH1A1HPGDHSD17B10L3MBTL1HTT | |
| SCHEMBL30357699 | 0.82 | LMNA (0.48) | ALDH1A1HSD17B10L3MBTL1TDP1CA9 | |
| SCHEMBL2263563 | 0.82 | LMNA (0.48) | ALDH1A1HSD17B10L3MBTL1TDP1CA9 | |
| SCHEMBL612939 | 0.81 | LMNA (0.58) | NSD2L3MBTL1HTTNPSR1NPC1 | |
| SCHEMBL28493030 | 0.81 | NSD2 (0.47) | NSD2ALDH1A1KDM4EHPGDALOX15 | |
| SCHEMBL2763826 | 0.81 | NSD2 (0.69) | NSD2ALDH1A1KDM4EHPGDALOX15 | |
| Hydrochloric Acid SCHEMBL27908422 | 0.80 | NSD2 (0.67) | NSD2ALDH1A1KDM4EHPGDALOX15 | |
| SCHEMBL29289316 | 0.80 | NSD2 (0.67) | NSD2ALDH1A1KDM4EHPGDALOX15 | |
| SCHEMBL295564 | 0.80 | ALDH1A1 (0.61) | ALDH1A1KDM4EHPGDALOX15HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025129193-A1 | GLYCOSYLTRANSFERASES AND RELATED METHODS | NEW ENGLAND BIOLABS, INC. (US) | 2025-06-19 | — | — | WO | disclosed |
| WO-2024088879-A1 | NANOPARTICLES FOR MEDICAL IMAGING AND TREATMENT | UNIVERSITÄT REGENSBURG (DE) | 2024-05-02 | — | — | WO | disclosed |
| EP-3469401-B1 | IMAGING TECHNOLOGIES | UNIV REGENSBURG (DE) | 2024-05-01 | — | — | EP | disclosed |
| EP-4360661-A1 | NANOPARTICLES FOR MEDICAL IMAGING AND TREATMENT | Universität Regensburg (DE) | 2024-05-01 | — | — | EP | disclosed |
| US-20230022745-A1 | Methods for Labeling a Population of RNA Molecules | NEW ENGLAND BIOLABS, INC. (US) | 2023-01-26 | — | — | US | disclosed |
| US-11479766-B2 | Methods for labeling a population of RNA molecules | NEW ENGLAND BIOLABS, INC. (US) | 2022-10-25 | — | — | US | disclosed |
| EP-3469401-A1 | IMAGING TECHNOLOGIES | Universitätsklinikum Regensburg (DE) | 2019-04-17 | — | — | EP | disclosed |
| US-20180195061-A1 | Methods for Labeling a Population of RNA Molecules | NEW ENGLAND BIOLABS, INC. (US) | 2018-07-12 | — | — | US | disclosed |
| EP-3279699-A1 | IMAGING TECHNOLOGIES | Universitätsklinikum Regensburg (DE) | 2018-02-07 | — | — | EP | disclosed |
| CN-103189063-B | therapeutic compositions and methods | 宾夕法尼亚州研究基金会 | 2016-10-19 | — | — | CN | disclosed |
| WO-2005040759-A2 | APPARATUS AND METHODS FOR DETECTING TARGET ANALYTE | DAKOTA TECHNOLOGIES, INC. (US) | 2005-05-06 | — | — | WO | disclosed |
| US-5512667-A | Trifunctional intermediates for preparing 3'-tailed oligonucleotides | DRUG ROYALTY LP1 (CA) | 1996-04-30 | — | — | US | disclosed |
| US-5419966-A | Solid support for synthesis of 3'-tailed oligonucleotides | MICROPROBE CORPORATION (US) | 1995-05-30 | — | — | US | disclosed |
| EP-0547142-A4 | — | MICROPROBE CORP (US) | 1995-01-18 | — | — | EP | disclosed |
| EP-0547142-A1 | SOLID SUPPORT SYNTHESIS OF 3'-TAILED OLIGONUCLEOTIDES VIA A LINKING MOLECULE | EPOCH PHARMACEUTICALS, INC. (US) | 1993-06-23 | — | — | EP | disclosed |
| WO-1992003464-A1 | SOLID SUPPORT SYNTHESIS OF 3'-TAILED OLIGONUCLEOTIDES VIA A LINKING MOLECULE | MICROPROBE CORPORATION (US) | 1992-03-05 | — | — | WO | disclosed |
| US-4168307-A | ANTICOAGULANTS | MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) | 1979-09-18 | — | — | US | disclosed |
| US-4154828-A | ANTITHROMBOGENIC | MITSUBISHI CHEMICAL INDUSTRIES, LTD. (JP) | 1979-05-15 | — | — | US | disclosed |
| US-4069329-A | INHIBITION AND SUPPRESSION OF THROMBOSIS | MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JA) | 1978-01-17 | — | — | US | disclosed |
| US-4062963-A | N2 -naphthalenesulfonyl-L-arginine derivatives, and the pharmaceutically acceptable acid addition salts thereof | MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JA) | 1977-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180195061-A1 | Methods for Labeling a Population of RNA Molecules | RNGTT, RNMT, MTAP | NSD2 2681/4885ALDH1A1 2357/4885KDM4E 1517/4885 |
| US-11479766-B2 | Methods for labeling a population of RNA molecules | RNGTT, RNMT, MTAP | NSD2 2681/4885ALDH1A1 2357/4885KDM4E 1517/4885 |
| US-20230022745-A1 | Methods for Labeling a Population of RNA Molecules | RNGTT, RNMT, MTAP | NSD2 2681/4885ALDH1A1 2357/4885KDM4E 1517/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.